Published 2000-01-01
“…A case in point was a few days last month during which I attended a well-sponsored meeting of the Ontario Lung
Association, reviewed a couple of papers reporting drug trials, read of the threats of litigation made by pharmaceutical companies to two Ontario researchers, heard of a public apology made by the New England Journal of Medicine regarding reviewers' conflicts of interest and received a critical letter from Dr Rob McFadden, an
associate editor of the
Canadian Respiratory Journal, about a sponsored publication that accompanied the last issue of 1999. …”
Get full text
Article
